Subscribe to Newsletter

Business & Regulation

Business & Regulation Business Practice

Social Media Reacts to Eli Lilly’s Price Reduction of Insulin

| Stephanie Vine | 4 min read

What does social media have to say about Eli Lilly’s insulin price reduction?

Business & Regulation Digital Technologies

Video: Matthew Lakelin on Improving Supply Chain Efficiency

| Rob Coker

A video interview covering supply chain improvement technology

Business & Regulation Profession

No One Left Behind

| Stephanie Vine | 10 min read

We speak with Eric Dube, CEO of Travere Therapeutics, about his career and thoughts on leadership.

Business & Regulation Business Practice

A Terrifying Awakening

| Rainer Lichtenberger | 8 min read

What are the lessons we must learn from the COVID-19 pandemic?

Business & Regulation Business Practice

A Roadmap to Greener Pharma Logistics

| Julius Graf von Pfeil, Kees Schmidt | 10 min read

How to make the art of pharmaceutical logistics more sustainable.

Business & Regulation Profession

Hybrid Theory

| Angus Stewart | 8 min read

Industry experience needn’t always come post-academia – other options are available, as we learned in our chat with this Northern Irish PhD candidate

Business & Regulation Marketing

Video: Kim Barnes on Post-Pandemic Pharma Events

| Stephanie Vine

A video interview tackling the post-pandemic challenges of the events industry

Business & Regulation Business Practice

Focusing on Sustainability

Download our eBook to find out how the industry is trying to be more sustainable.

Business & Regulation Trends & Forecasts

Weathering the Storm: Cell and Gene’s Economic Downturn

| James Wilson, Anshul Mangal | 5 min read

An early wave of investor enthusiasm followed by an economic crisis has landed our field in a sea of trouble – so how can we swim to shore?

Business & Regulation Business Practice

Here Come the Humira Biosimilars

| Stephanie Vine | 2 min read

The first Humira biosimilar in the US is here, but market penetration could be a challenge.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register